Your browser is no longer supported. Please, upgrade your browser.
Settings
RMD ResMed Inc. daily Stock Chart
RMD [NYSE]
ResMed Inc.
Index- P/E28.35 EPS (ttm)2.46 Insider Own0.80% Shs Outstand140.79M Perf Week8.63%
Market Cap9.82B Forward P/E22.67 EPS next Y3.08 Insider Trans-23.24% Shs Float140.56M Perf Month13.15%
Income348.10M PEG2.77 EPS next Q0.70 Inst Own65.70% Short Float11.43% Perf Quarter10.04%
Sales1.89B P/S5.19 EPS this Y0.70% Inst Trans-0.05% Short Ratio18.11 Perf Half Y7.54%
Book/sh12.59 P/B5.54 EPS next Y10.57% ROA12.40% Target Price61.76 Perf Year21.36%
Cash/sh5.55 P/C12.56 EPS next 5Y10.25% ROE20.90% 52W Range54.28 - 70.17 Perf YTD12.36%
Dividend1.32 P/FCF46.76 EPS past 5Y11.50% ROI11.90% 52W High-0.64% Beta0.81
Dividend %1.89% Quick Ratio2.00 Sales past 5Y8.10% Gross Margin58.00% 52W Low28.45% ATR1.51
Employees5250 Current Ratio2.40 Sales Q/Q13.10% Oper. Margin22.50% RSI (14)77.47 Volatility2.14% 1.64%
OptionableYes Debt/Eq0.66 EPS Q/Q-8.10% Profit Margin18.40% Rel Volume4.78 Prev Close63.60
ShortableYes LT Debt/Eq0.49 EarningsJan 23 AMC Payout49.60% Avg Volume887.31K Price69.72
Recom2.90 SMA2010.77% SMA5013.64% SMA20012.48% Volume4,239,497 Change9.62%
Jan-24-17Upgrade JP Morgan Neutral → Overweight
Jan-24-17Reiterated Canaccord Genuity Hold $55 → $59
Oct-04-16Initiated JP Morgan Neutral $64
Aug-23-16Downgrade Jefferies Hold → Underperform
Jun-27-16Downgrade Needham Hold → Underperform
Apr-28-16Upgrade Macquarie Underperform → Neutral
Apr-27-16Downgrade Piper Jaffray Overweight → Neutral
Apr-07-16Resumed Barclays Underweight $55
Jan-22-16Upgrade Credit Suisse Neutral → Outperform
Jan-19-16Downgrade Barclays Equal Weight → Underweight $61 → $52
Dec-17-15Downgrade Needham Buy → Hold
Jul-13-15Downgrade Macquarie Neutral → Underperform
Jun-25-15Initiated Barclays Equal Weight $61
May-14-15Reiterated Needham Buy $77 → $65
May-13-15Downgrade BofA/Merrill Buy → Neutral
Apr-27-15Downgrade Goldman Buy → Neutral
Apr-24-15Downgrade Macquarie Outperform → Neutral
Jan-27-15Reiterated Northland Capital Under Perform $40 → $44
Jan-23-15Upgrade Needham Hold → Buy
Jan-23-15Reiterated Canaccord Genuity Hold $42 → $50
Jan-24-17 04:32PM  ResMed stock surges after strong quarterly results at CNBC +9.62%
04:27PM  Breaking Out: ResMed Stock Launches As Fiscal Q2 Sales, EPS Beat
03:08PM  ResMed Reports Q2 Profit of $76.7M (RMD) at Investopedia
12:48PM  Why ResMed Is in the Green Today at Motley Fool
10:57AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q2, 2017 By the Numbers : January 24, 2017
09:04AM  Morning Movers: Lockheed Martin Tumbles, Johnson & Johnson Slips, AK Steel Soars at Barrons.com
08:12AM  ResMed (RMD) Beats Earnings and Revenue Estimates in Q2
07:49AM  ResMed upgraded by JP Morgan
01:09AM  BlueScope, ResMed news boosts share market Other
Jan-23-17 08:43PM  ResMed Q2 profit down but revenue up Other
08:42PM  Edited Transcript of RMD earnings conference call or presentation 23-Jan-17 9:30pm GMT
06:04PM  After hours buzz: YHOO, RMD, MRCY at CNBC
04:14PM  ResMed tops Street 2Q forecasts AP
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
04:05PM  ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2017 PR Newswire
07:07AM  Q2 2017 ResMed Inc Earnings Release - 4:00 pm ET
Jan-20-17 05:28PM  ResMed and BMC/3B Medical Settle Global Litigation PR Newswire
08:14AM  Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD Other
Jan-18-17 01:04PM  RESMED INC Financials
Jan-13-17 06:37AM  ResMed (RMD) Q2 Earnings: Disappointment in the Cards? Zacks
Jan-12-17 04:26PM  RESMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
03:00AM  ResMed's myAir Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea PR Newswire
Jan-11-17 07:27AM  Why a Massive Short Squeeze Could Send These 4 Stocks Into Orbit at TheStreet
Jan-09-17 09:00AM  FDA Clears World's Smallest CPAP, ResMed AirMini PR Newswire
07:30AM  ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders Zacks
Jan-07-17 09:48PM  CES: These Gadgets Will Literally Put You To Sleep at Investor's Business Daily
Jan-06-17 04:48PM  [$$] Pegasus Teams Up With Dr. Oz, ResMed to Launch SleepScore Labs at The Wall Street Journal
02:30PM  Largest Consumer Sleep Study Just Released at CES 2017 Business Wire
09:00AM  Dr. Oz, ResMed Launch SleepScore Labs - Promising the World a Better Night's Sleep PR Newswire
Jan-05-17 06:52AM  ResMed Achieves Key Milestone in Sleep-Disordered Breathing Zacks
Jan-04-17 09:00AM  ResMed Reaches Historic One Billionth Night of Sleep Monitored PR Newswire
09:00AM  ResMed Reaches Historic One Billionth Night of Sleep Monitored CNW Group
Dec-29-16 08:02AM  ResMed: SDB Business Faces Risks, Reimbursement a Drag Zacks
Dec-23-16 09:21AM  What Do Analysts Recommend for Baxter International?
Dec-20-16 09:00AM  ResMed Appoints Carlos Nunez, MD, as Chief Medical Officer PR Newswire
09:00AM  ResMed Appoints Carlos Nunez, MD, as Chief Medical Officer CNW Group
Dec-19-16 04:05PM  ResMed to Announce Second Quarter Fiscal Year 2017 Results PR Newswire
Dec-04-16 12:59PM  Should You Add ResMed Inc. (RMD) to Your Portfolio? at Insider Monkey
Dec-01-16 04:18PM  ResMed loses in Fisher &Paykel; dispute Other
04:18PM  Fisher & Paykel wins German court case against ResMed Reuters
11:20AM  ETFs with exposure to ResMed, Inc. : December 1, 2016
Nov-30-16 07:12AM  ResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : November 30, 2016
Nov-18-16 02:33PM  RESMED INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-01-16 09:05AM  ResMed Launches AirView Action Groups, the Ultimate Time-saver For Home Medical Equipment Providers PR Newswire
09:05AM  ResMed Launches AirView Action Groups, the Ultimate Time-saver For Home Medical Equipment Providers CNW Group
09:00AM  ResMed Introduces AirFit(TM) N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort PR Newswire
09:00AM  ResMed Introduces AirFit N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort PR Newswire
09:00AM  ResMed Introduces AirFit N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort CNW Group
Oct-31-16 02:06PM  ETFs with exposure to ResMed, Inc. : October 31, 2016
Oct-28-16 06:06AM  RESMED INC Files SEC form 10-Q, Quarterly Report
Oct-26-16 02:28PM  ResMed (RMD) Stock Sharply Lower After Q1 Results Miss Estimates at TheStreet -5.58%
10:40AM  ResMed (RMD) Misses Earnings & Revenue Estimates in Q1
09:46AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q1, 2017 By the Numbers : October 26, 2016
01:41AM  ResMed slips on first quarter income drop Other
Oct-25-16 09:18PM  Edited Transcript of RMD earnings conference call or presentation 25-Oct-16 8:30pm GMT
08:25PM  ResMed's profit down despite revenue rise Other
04:11PM  ResMed misses Street 1Q forecasts AP
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
04:05PM  ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2017 PR Newswire
09:00AM  Results from World's Largest Study on Sleep Apnea and Digital Connected Care PR Newswire
09:00AM  Results from World's Largest Study on Sleep Apnea and Digital Connected Care CNW Group
07:07AM  Q1 2017 ResMed Inc Earnings Release - After Market Close
Oct-24-16 07:47AM  Medical Product Oct 25 Earnings Roster: BAX, RMD, CPHD, EW Zacks
06:15AM  How Technology is Tackling the World's Greatest Healthcare Challenges in the Era of Personalized Medicine, at the Digital Health Summit at CES 2017 PR Newswire
Oct-19-16 01:45PM  ETFs with exposure to ResMed, Inc. : October 19, 2016
Oct-18-16 09:00AM  National Sleep Survey Launch on "The Dr. Oz Show" to Determine America's Sleep Score PR Newswire
08:23AM  What's in the Cards for ResMed (RMD) in Q1 Earnings? Other
Oct-14-16 09:00AM  Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System PR Newswire
Sep-29-16 12:34PM  ResMed Boosted To Buy At Bank Of America Benzinga
Sep-27-16 04:05PM  ResMed to Announce First Quarter Fiscal Year 2017 Results PR Newswire
Sep-19-16 12:59PM  U.S. trade authorities to probe some imported sleep disorder systems Reuters
Sep-12-16 08:04AM  Why Did Valspars Coatings Segment Revenue Fall in 3Q16?
Sep-09-16 08:21AM  ResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : September 9, 2016
Sep-08-16 06:00AM  Jim Cramer's Top Takeaways: Dave & Buster's, Starbucks, Chipotle, ResMed at TheStreet
Sep-07-16 07:34PM  Cramer Remix: Why the supermarkets are crumbling at CNBC
Sep-06-16 11:10AM  ETFs with exposure to ResMed, Inc. : September 6, 2016
08:50AM  New Study Shows Using Non-Invasive Ventilation Therapy to Treat Patients with Chronic Obstructive Pulmonary Disorder (COPD) at Home Significantly Reduces Risk of Re-Hospitalization and Death PR Newswire
01:00AM  ResMed Expands COPD Offering as New Data Reveals Benefits of Home Non-Invasive Ventilation Business Wire
Aug-25-16 11:30AM  Rising Street Value Of ResMed Shares Disconnected From Its Fundamentals Benzinga
Aug-23-16 04:14PM  Square, United Rated Buys; Logitech, ResMed Downgraded
03:23PM  ResMed (RMD) Stock Slides, Jefferies Downgrades to 'Underperform' at TheStreet
Aug-22-16 11:58AM  ETFs with exposure to ResMed, Inc. : August 22, 2016
09:24AM  ResMed, Inc. :RMD-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016
Aug-18-16 07:54AM  Early movers: WMT, HRL, TWTR, PCLN, CSCO, LB, NTAP, A, GPRO, SCTY & more at CNBC
12:15AM  ResMed, Fisher & Paykel in patent spat Other
Aug-17-16 08:10PM  ResMed seeks patent injunction on Fisher & Paykel Healthcare Reuters
05:58PM  ResMed files legal action against Fisher & Paykel Healthcare Reuters
05:10PM  ResMed Takes Fisher & Paykel to Court over Patents PR Newswire
05:10PM  ResMed Takes Fisher & Paykel to Court over Patents CNW Group
Aug-12-16 12:15PM  Insider Buying Volume Hitting Historic Lows Should Not Worry Investors; Noteworthy Insider Transactions at 5 Companies at Insider Monkey
Aug-08-16 02:39PM  ETFs with exposure to ResMed, Inc. : August 8, 2016
Aug-05-16 05:14PM  RESMED INC Files SEC form 10-K, Annual Report
10:12AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q4, 2016 By the Numbers : August 5, 2016
Aug-04-16 01:40AM  ResMed, Inc. :RMD-AU: Earnings Analysis: Q4, 2016 By the Numbers : August 4, 2016
01:25AM  ResMed, Inc. :RMD-AU: Earnings Analysis: 2016 By the Numbers : August 4, 2016
Jul-29-16 11:11AM  Edited Transcript of RMD earnings conference call or presentation 28-Jul-16 8:30pm GMT
10:14AM  ResMed (RMD) Q4 Earnings in Line, Revenues Top Estimates Zacks
Jul-28-16 11:03PM  ResMed annual profit flat at $US352m Other
06:06PM  ResMed meets 4Q profit forecasts AP
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
ResMed Inc. designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. Its portfolio of products include devices, such as air flow generators, ventilators, and oxygen concentrators; diagnostic products; mask systems; headgear and other accessories; dental devices; portable oxygen concentrators; and cloud-based software informatics solutions. The company also produces continuous positive airway pressure, variable positive airway pressure, and AutoSet systems for the titration and treatment of sleep disordered breathing (SDB). In addition, it offers data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hollingshead JamesPresident, AmericasJan 17Option Exercise43.635,264229,66846,754Jan 19 05:22 PM
Hollingshead JamesPresident, AmericasJan 17Sale64.447,084456,49339,670Jan 19 05:22 PM
FARRELL PETER CDirectorJan 04Option Exercise33.7020,000674,000321,557Jan 05 05:24 PM
FARRELL PETER CDirectorJan 04Sale62.1420,0001,242,760301,557Jan 05 05:24 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Option Exercise27.586,365175,54784,261Jan 04 04:01 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Sale61.956,365394,31277,896Jan 04 04:01 PM
FARRELL PETER CDirectorDec 05Option Exercise33.7020,000674,000372,407Dec 06 04:49 PM
PENDARVIS DAVIDChief Administrative OfficerDec 05Option Exercise27.586,365175,54784,261Dec 06 04:50 PM
PENDARVIS DAVIDChief Administrative OfficerDec 05Sale60.006,365381,90077,896Dec 06 04:50 PM
FARRELL PETER CDirectorDec 05Sale59.8320,0001,196,540352,407Dec 06 04:49 PM
FARRELL PETER CDirectorNov 04Option Exercise33.7020,000674,000367,978Nov 07 02:16 PM
FARRELL PETER CDirectorNov 04Sale57.2820,0001,145,560347,978Nov 07 02:16 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Option Exercise33.706,033203,31287,306Nov 07 11:40 AM
PENDARVIS DAVIDChief Administrative OfficerNov 03Sale57.796,033348,64781,273Nov 07 11:40 AM
ROBERTS CHRISTOPHER GDirectorOct 19Option Exercise25.5436,000919,440145,610Oct 24 12:27 PM
Hollingshead JamesPresident, AmericasOct 18Sale64.711,967127,28545,513Oct 19 08:09 PM
Farrell Michael J.Chief Executive OfficerOct 17Option Exercise33.705,975201,358203,781Oct 18 03:49 PM
Hollingshead JamesPresident, AmericasOct 17Option Exercise43.635,264229,66852,744Oct 18 08:13 PM
Farrell Michael J.Chief Executive OfficerOct 17Sale64.255,975383,870197,806Oct 18 03:49 PM
Hollingshead JamesPresident, AmericasOct 17Sale64.435,264339,16047,480Oct 18 08:13 PM
FARRELL PETER CDirectorOct 04Option Exercise27.1420,000542,746367,978Oct 06 03:59 PM
FARRELL PETER CDirectorOct 04Sale64.7020,0001,293,960347,978Oct 06 03:59 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Option Exercise33.706,000202,20087,061Oct 04 05:30 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Sale63.956,000383,71881,061Oct 04 05:30 PM
Farrell Michael J.Chief Executive OfficerSep 15Option Exercise33.705,975201,358203,781Sep 16 09:15 PM
Farrell Michael J.Chief Executive OfficerSep 15Sale64.845,975387,419197,806Sep 16 09:15 PM
PENDARVIS DAVIDChief Administrative OfficerSep 06Option Exercise33.706,000202,20087,061Sep 08 12:43 PM
FARRELL PETER CDirectorSep 06Option Exercise25.5420,000510,800367,978Sep 08 12:44 PM
FARRELL PETER CDirectorSep 06Sale67.2920,0001,345,760347,978Sep 08 12:44 PM
PENDARVIS DAVIDChief Administrative OfficerSep 06Sale67.186,000403,05081,061Sep 08 12:43 PM
PACE GARY WDirectorAug 19Option Exercise25.5436,000919,440129,158Aug 22 06:18 PM
PACE GARY WDirectorAug 19Sale69.9336,0002,517,33693,158Aug 22 06:18 PM
TAYLOR RONALD RDirectorAug 17Buy69.132,487171,92619,216Aug 17 09:08 PM
TAYLOR RONALD RDirectorAug 16Sale69.2523,1021,599,81416,729Aug 17 09:08 PM
Farrell Michael J.Chief Executive OfficerAug 15Option Exercise33.705,975201,358154,814Aug 15 07:55 PM
Farrell Michael J.Chief Executive OfficerAug 15Sale70.415,975420,700148,839Aug 15 07:55 PM
Sandercock BrettChief Financial OfficerAug 11Sale70.5035,0002,467,50051,084Aug 11 07:33 PM
SULPIZIO RICHARDDirectorAug 10Option Exercise25.5436,000919,440101,887Aug 11 02:31 PM
SULPIZIO RICHARDDirectorAug 10Sale70.1536,0002,525,29265,887Aug 11 02:31 PM
WAREHAM JOHN PDirectorAug 08Option Exercise33.7024,390821,94337,390Aug 10 12:14 PM
WAREHAM JOHN PDirectorAug 08Sale70.3224,3901,714,98313,000Aug 10 12:14 PM
FARRELL PETER CDirectorAug 04Option Exercise25.5420,000510,800367,978Aug 05 08:31 PM
FARRELL PETER CDirectorAug 04Sale69.1620,0001,383,260347,978Aug 05 08:31 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Option Exercise33.706,000202,20080,512Aug 05 11:42 AM
PENDARVIS DAVIDChief Administrative OfficerAug 03Sale68.866,000413,13674,512Aug 05 11:42 AM
Farrell Michael J.Chief Executive OfficerJul 15Option Exercise33.705,975201,358154,814Jul 19 04:23 PM
Farrell Michael J.Chief Executive OfficerJul 15Sale65.035,975388,554148,839Jul 19 04:23 PM
Hollingshead JamesPresident, AmericasJul 14Sale65.022,753178,99440,669Jul 14 09:24 PM
FARRELL PETER CDirectorJul 07Sale63.6220,0001,272,400347,978Jul 07 06:17 PM
PENDARVIS DAVIDChief Administrative OfficerJul 05Option Exercise33.706,000202,20080,512Jul 06 04:47 PM
FARRELL PETER CDirectorJul 05Option Exercise25.5420,000510,800367,978Jul 07 06:17 PM
PENDARVIS DAVIDChief Administrative OfficerJul 05Sale63.626,000381,72074,512Jul 06 04:47 PM
Farrell Michael J.Chief Executive OfficerJun 15Option Exercise33.705,975201,358154,814Jun 16 02:37 PM
Farrell Michael J.Chief Executive OfficerJun 15Sale59.635,975356,289148,839Jun 16 02:37 PM
Hollingshead JamesPresident, AmericasJun 15Sale59.404,458264,82743,422Jun 16 12:54 PM
FARRELL PETER CDirectorJun 06Option Exercise25.5420,000510,800367,978Jun 08 01:52 PM
FARRELL PETER CDirectorJun 06Sale59.8220,0001,196,400347,978Jun 08 01:52 PM
PENDARVIS DAVIDChief Administrative OfficerJun 03Option Exercise33.706,000202,20080,512Jun 06 05:22 PM
PENDARVIS DAVIDChief Administrative OfficerJun 03Sale59.416,000356,46074,512Jun 06 05:22 PM
Farrell Michael J.Chief Executive OfficerMay 16Option Exercise33.705,975201,358154,723May 17 06:10 PM
Farrell Michael J.Chief Executive OfficerMay 16Sale57.645,975344,369148,748May 17 06:10 PM
FARRELL PETER CDirectorMay 04Option Exercise25.5420,000510,800367,978May 06 12:25 PM
FARRELL PETER CDirectorMay 04Sale55.9020,0001,118,000347,978May 06 12:25 PM
PENDARVIS DAVIDChief Administrative OfficerMay 03Option Exercise33.706,000202,20080,287May 05 09:08 AM
PENDARVIS DAVIDChief Administrative OfficerMay 03Sale56.026,000336,12074,287May 05 09:08 AM
Farrell Michael J.Chief Executive OfficerApr 15Option Exercise33.705,975201,358154,723Apr 19 02:46 PM
Farrell Michael J.Chief Executive OfficerApr 15Sale59.345,975354,557148,748Apr 19 02:46 PM
PENDARVIS DAVIDChief Administrative OfficerApr 04Option Exercise33.706,000202,20080,287Apr 05 02:53 PM
FARRELL PETER CDirectorApr 04Option Exercise25.5420,000510,800367,978Apr 05 03:06 PM
FARRELL PETER CDirectorApr 04Sale57.5120,0001,150,200347,978Apr 05 03:06 PM
PENDARVIS DAVIDChief Administrative OfficerApr 04Sale58.706,000352,20074,287Apr 05 02:53 PM
Farrell Michael J.Chief Executive OfficerMar 15Option Exercise33.705,975201,358150,852Mar 17 07:51 PM
Farrell Michael J.Chief Executive OfficerMar 15Sale58.575,975349,956144,877Mar 17 07:51 PM
Hollingshead JamesPresident, AmericasMar 15Sale58.574,500263,56747,569Mar 16 08:39 PM
PACE GARY WDirectorMar 11Option Exercise23.8836,000859,500129,158Mar 14 12:47 PM
PACE GARY WDirectorMar 11Sale60.0036,0002,160,00093,158Mar 14 12:47 PM
FARRELL PETER CDirectorMar 04Option Exercise25.5420,000510,800367,978Mar 07 07:03 PM
FARRELL PETER CDirectorMar 04Sale57.5120,0001,150,200347,978Mar 07 07:03 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Option Exercise33.706,000202,20080,287Mar 07 03:17 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Sale57.266,000343,56074,287Mar 07 03:17 PM
Reiser AnnePresident - ResMed EuropeFeb 29Sale57.061,946111,03976,300Mar 02 01:15 PM
SULPIZIO RICHARDDirectorFeb 26Option Exercise23.8836,000859,500101,887Feb 29 01:32 PM
SULPIZIO RICHARDDirectorFeb 26Sale57.8836,0002,083,68065,887Feb 29 01:32 PM
Sandercock BrettChief Financial OfficerFeb 26Sale57.6312,809738,223119,327Feb 29 10:34 AM
FARRELL PETER CDirectorFeb 25Sale57.31139,9808,022,2540Feb 29 01:29 PM
Sandercock BrettChief Financial OfficerFeb 25Sale57.5917,191990,030132,136Feb 29 10:34 AM
Reiser AnnePresident - ResMed EuropeFeb 23Option Exercise20.363,00061,06579,300Feb 26 09:34 AM
FARRELL PETER CDirectorFeb 04Option Exercise25.5420,000510,800367,978Feb 08 09:53 PM
FARRELL PETER CDirectorFeb 04Sale57.7020,0001,154,000347,978Feb 08 09:53 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Option Exercise33.706,000202,20080,287Feb 05 12:41 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Sale57.436,000344,56874,287Feb 05 12:41 PM